Aclaris Therapeutics Inc (ACRS)
SG&A Expenses
$23.24M
TTM · Period ending: · USD
ACRS SG&A Expenses
Latest reported$23.24Mperiod ending
Latest reported$23.24Mperiod ending
ACRS TTM SG&A Expenses ($2.03M → $23.24M)
TTM SG&A Expenses
High-resolution chart · PNG
ACRS sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 23,238,000 | |
| 22,576,000 | |
| 21,972,000 | |
| 21,350,000 | |
| 22,132,000 | |
| 21,398,000 | |
| 22,103,000 | |
| 25,363,000 | |
| 26,508,000 | |
| 29,152,000 | |
| 31,098,000 | |
| 30,030,000 | |
| 29,045,000 | |
| 27,824,000 | |
| 25,133,000 | |
| 24,930,000 | |
| 25,096,000 | |
| 24,891,000 | |
| 23,619,000 | |
| 21,575,000 | |
| 19,455,000 | |
| 19,157,000 | |
| 20,530,000 | |
| 22,239,000 | |
| 24,666,000 | |
| 34,261,000 | |
| 46,082,000 | |
| 59,135,000 | |
| 70,803,000 | |
| 74,625,000 | |
| 74,097,000 | |
| 66,428,000 | |
| 56,597,000 | |
| 43,938,000 | |
| 31,603,000 | |
| 24,295,000 | |
| 19,822,000 | |
| 16,645,000 | |
| 15,091,000 | |
| 12,807,000 | |
| 10,389,000 | |
| 8,039,000 | |
| 5,327,000 | |
| 3,475,000 | |
| 2,808,000 | |
| 2,461,500 | |
| 2,026,000 |